Journals / Türk Oftalmoloji Dergisi / 2014 / Cilt: 44 - Sayı: 4

Marginal ZoneB-CellLymphoma of the lacrimal gland secondary to sjogren s syndrome

Sjögren sendromuna ikincil gelişen lakrimal glandın marjinal Zon B Hücreli lenfoması

Pages
322–324
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this articlewe aimed to present a very rare case of marginal zone B-cell lymphoma in the lacrimal gland secondary to Sjogren s syndrome. (Turk J Ophthalmol 2014; 44: 322-4)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sjogren s syndrome is a chronic, autoimmune, inflammatory disease which can affect all exocrine glands, particularly the salivary and lacrimal glands, causing dryness of the mouth and eyes.
📊
Key Findings & Data:The most serious complication is the development of lymphoma.
💡
Conclusion & Impact:In this articlewe aimed to present a very rare case of marginal zone B-cell lymphoma in the lacrimal gland secondary to Sjogren s syndrome. (Turk J Ophthalmol 2014; 44: 322-4)
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Sjogren s syndrome is a chronic, autoimmune, inflammatory disease which can affect all exocrine glands, particularly the salivary and lacrimal glands, causing dryness of the mouth and eyes. The most serious complication is the development of lymphoma. In this articlewe aimed to present a very rare case of marginal zone B-cell lymphoma in the lacrimal gland secondary to Sjogren s syndrome. (Turk J Ophthalmol 2014; 44: 322-4)

Özet

Sjögren sendromu, tüm ekzokrin bezleri, özellikle de tükürük ve lakrimal bezleri tutarak ağız ve göz kuruluğuna neden olan kronik, otoimmun, inflamatuar bir hastalıktır. Lenfoma gelişimi en ciddi komplikasyonudur. Bu makalede oldukça nadir görülen, Sjögren sendromuna ikincil lakrimal bezde gelişen marginal zon B hücreli lenfomalı bir olgunun sunulması amaçlanmıştır. (Turk J Ophthalmol 2014; 44: 322-4)

🔖

Cite This Article

AKKAYA, B., TÜRKOĞLU, E. B., ÜNAL, M., BİLGİN, A. B., DENİZ, H. İ. (2022). Marginal ZoneB-CellLymphoma of the lacrimal gland secondary to sjogren s syndrome. Türk Oftalmoloji Dergisi, Cilt: 44 - Sayı: 4, 322–324. https://ajindex.com/articles/638035

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Özkal S. Güncel Lenfoma Sınıflandırması. Turkiye Klinikleri J Hem OncSpecial Topics. 2012;5:1-8.
  2. Tonami H, Matoba M, Yokota H, Higashi K, Yamamoto I, Sugai S. Mucosa associated lymphoid tissue lymphoma in Sjögren’s syndrome: initial and follow-up imaging features. AJR Am J Roentgenol. 2002;179:485-9.
  3. Royer B, Cazals-Hatem D, Sibilia J, et al. Lymphomas in patients with Sjogren’s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, anda re not associated with viruses. Blood1997;90:766-75.
  4. Ruiz A, Reischl U, Swerdlow SH, et al. Extranodal marginal zone B-cellymphomas of the ocular adnexa: multiparameter analysis of 34 caseincluding interphase molecular cytogenetics and PCR for Chlamydia psittaciAm J Surg Pathol. 2007;31:792-802.
  5. Kao SC, Kau HC, Tsai CC, et al. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type. Am J Ophthalmol. 2007;143:311-6.
  6. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98:51-60.
  7. Abu Shakral M, Ehrenfeld M, Shoenfeld Y. Systemic lupus erythematosus and cancer: associated or not? Lupus. 2002;11:137-44.
  8. Asproudis I, Gorezis S, Charonis GC, Tolis C, Tsanou E, Agnantis NJ. Mucosa associated lymphoid tissue lymphoma of the lacrimal gland: a case report. In Vivo. 2005;19:1105-9.
  9. Heinz C, Merz H, Nieschalk M, et al. Rituximab fort the treatment oextranodal marginal zone B-cell lymphoma of the lacrimal gland. Br J Ophthalmol. 2007;91:1563-4.
  10. Charlotte F, Doghmi K, Cassoux N, et al. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases. Virchows Arch2006;448:506-16.
  11. Portlock CS, Rosenberg SA. No initial therapy for stage III and IV nonHodgkin’s lymphomas of favorable histologic types. Ann Intern Med1979;90:10-3.